RCM Technologies Inc. (RCMT)
NASDAQ: RCMT
· Real-Time Price · USD
26.80
-0.02 (-0.06%)
At close: Sep 24, 2025, 3:59 PM
26.26
-2.00%
After-hours: Sep 24, 2025, 06:50 PM EDT
-0.06% (1D)
Bid | 25.6 |
Market Cap | 198.56M |
Revenue (ttm) | 299.92M |
Net Income (ttm) | 13.58M |
EPS (ttm) | 1.77 |
PE Ratio (ttm) | 15.14 |
Forward PE | 10.33 |
Analyst | Strong Buy |
Dividends | n/a |
Ask | 28 |
Volume | 22,925 |
Avg. Volume (20D) | 61,287 |
Open | 27.00 |
Previous Close | 26.82 |
Day's Range | 26.68 - 27.30 |
52-Week Range | 13.18 - 28.27 |
Beta | 0.26 |
Ex-Dividend Date | n/a |
About RCMT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RCMT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RCMT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsRCM Technologies Inc. is scheduled to release its earnings on
Nov 6, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
+15.9%
RCM Technologies shares are trading higher after t...
Unlock content with
Pro Subscription
6 months ago
-13.45%
RCM Technologies shares are trading lower after the company reported worse-than-expected Q4 financial results.

2 weeks ago · businesswire.com
Cosentus Invests in Accreda Healthcare Management — An Anesthesia-Exclusive RCM ProviderIRVINE, Calif.--(BUSINESS WIRE)---- $RCM #Accreda--Cosentus invests in Accreda, an anesthesia-exclusive RCM provider, enhancing coding accuracy, claims processing & revenue performance.